telmisartan has been researched along with Astrocytoma, Grade IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Li, C; Wang, Y; Xu, B; Xue, L; Zhang, T | 1 |
1 other study(ies) available for telmisartan and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation.
Topics: Benzimidazoles; Benzoates; Cell Proliferation; Glioblastoma; Humans; Lipid Metabolism; Lipids; PPAR gamma; Telmisartan | 2022 |